Causes of death
| . | Total . | Age of <65 y . | Age of ≥65 . | P value . |
|---|---|---|---|---|
| Total deaths | 73 | 39 (53.4) | 34 (46.5) | .37 |
| Myeloma-related deaths | 55 (75.34) | 31 (79.49) | 24 (70.59) | .31 |
| Nonrelapse mortality | 18 (24.66) | 8 (20.51) | 10 (29.41) | |
| Nonrelapse mortality categories | .22 | |||
| Cardiac | 3 (4.11) | 0 (0.0) | 3 (8.82) | |
| Infection (COVID-19, bacteremia, etc) | 10 (13.70) | 5 (12.82) | 5 (14.71) | |
| Toxicity (CRS/ICANS) | 1 (1.37) | 1 (2.56) | 0 (0.0) | |
| Neurotoxicity, unspecified | 1 (1.37) | 1 (2.56) | 0 (0.0) | |
| Lewy-body dementia | 1 (1.37) | 0 (0.0) | 1 (2.94) | |
| Unspecified | 2 (2.74) | 1 (2.56) | 1 (2.94) |
| . | Total . | Age of <65 y . | Age of ≥65 . | P value . |
|---|---|---|---|---|
| Total deaths | 73 | 39 (53.4) | 34 (46.5) | .37 |
| Myeloma-related deaths | 55 (75.34) | 31 (79.49) | 24 (70.59) | .31 |
| Nonrelapse mortality | 18 (24.66) | 8 (20.51) | 10 (29.41) | |
| Nonrelapse mortality categories | .22 | |||
| Cardiac | 3 (4.11) | 0 (0.0) | 3 (8.82) | |
| Infection (COVID-19, bacteremia, etc) | 10 (13.70) | 5 (12.82) | 5 (14.71) | |
| Toxicity (CRS/ICANS) | 1 (1.37) | 1 (2.56) | 0 (0.0) | |
| Neurotoxicity, unspecified | 1 (1.37) | 1 (2.56) | 0 (0.0) | |
| Lewy-body dementia | 1 (1.37) | 0 (0.0) | 1 (2.94) | |
| Unspecified | 2 (2.74) | 1 (2.56) | 1 (2.94) |